Sensyne strikes one-year agreement with Exscientia
24th Dec 2021 08:25
(Sharecast News) - Clinical artificial intelligence company Sensyne Health has struck a one-year agreement with Exscientia to leverage "the deep learning AI capabilities" of its platform to study real-world health data.
Read moreSensyne signs five-year patient data deal with Cambridge NHS trust
3rd Dec 2021 14:42
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year, non-exclusive strategic research agreement with Cambridge University Hospitals NHS Foundation Trust, it announced on Friday.
Read moreSensyne enters health data partnership with US-based OMNY
15th Oct 2021 14:44
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced a new strategic relationship with US-based data network company OMNY Health on Friday.
Read moreSensyne Health signs five-year research deal with GOSH
2nd Sep 2021 12:29
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year non-exclusive strategic research agreement with the Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), it announced on Thursday, to analyse anonymised patient data using clinical AI technology.
Read moreSensyne Health appoints new scientific chief
22nd Jul 2021 12:26
(Sharecast News) - Artificial intelligence (AI) company Sensyne Health announced the appointment of Dr David Ruau to the newly-created role of chief scientific officer on Thursday, with effect from 1 September.
Read moreSensyne Health FY trading comes in ahead of expectations
27th May 2021 11:26
(Sharecast News) - Clinical AI company Sensyne Health said on Thursday that its full-year trading performance had come in ahead of expectations.
Read moreSensyne signs second US strategic research deal
24th May 2021 11:21
(Sharecast News) - Clinical artificial intelligence (AI) Sensyne Health has signed its second strategic research agreement in the United States, it announced on Monday, with the Colorado Center for Personalized Medicine (CCPM), a partnership between nonprofit health system UCHealth and the University of Colorado Anschutz Medical Campus.
Read moreSensyne's 'MagnifEye' gets MHRA special use authorisation
7th May 2021 08:55
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Friday that its 'MagnifEye' software application, which uses AI to automate the accurate reading and analysis of lateral flow diagnostic tests, has been granted special use authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).
Read moreSensyne Health signs research deal with another NHS trust
30th Apr 2021 14:45
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year non-exclusive strategic research agreement (SRA) with the Royal Devon and Exeter NHS Foundation Trust, it announced on Friday.
Read moreSensyne signs £0.5m Covid-19 test deal with DHSC
12th Mar 2021 09:23
(Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health has signed a £0.47m agreement with the Department of Health and Social Care, it announced on Friday, to conduct the second stage of a pilot study of its 'MagnifEye' technology for use with Covid-19 lateral flow diagnostic tests.
Read moreSensyne Health gets UK approval for 'SYNE-COV' algorithm
1st Mar 2021 15:36
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'SYNE-COV' machine learning algorithm for Covid-19 risk prediction has achieved regulatory approval for use in the UK.
Read moreSensyne Health signs licence agreement with Excalibur
9th Feb 2021 14:43
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed an exclusive licence and development agreement with Excalibur Healthcare Services, it announced on Tuesday, to apply Sensyne's 'MagnifEye' system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications, including its Covid-19 antigen test currently being marketed in the UK and Europe.
Read moreSensyne Health signs five-year deal with NHS Hampshire Hospitals
25th Nov 2020 15:07
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five year non-exclusive strategic research agreement with Hampshire Hospitals NHS Foundation Trust, it announced on Wednesday.
Read moreSensyne taps Derek Baird to lead North American expansion
13th Nov 2020 09:25
(Sharecast News) - Clinical AI company Sensyne has tapped Derek Baird to take on the role of North American president as the group looks to advance its expansion into the region.
Read moreSensyne Health app to be used in Covid-19 study
2nd Nov 2020 09:27
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'CVm-Health+' app is to be used by the University of Oxford in its 'FACTS' clinical study evaluating the feasibility and acceptability of new point-of-care tests for regular asymptomatic Covid-19 testing in the community.
Read more